National Institutes of Health
- The primary NIH organization for research on Ataxia Telangiectasia is the National Institute of Neurological Disorders and Stroke
Ataxia-telangiectasia (AT) is a rare, inherited disease. It affects the nervous system, immune system, and other body systems. Symptoms appear in young children, usually before age 5. They include
People with AT have an increased risk of developing diabetes and cancers, particularly lymphoma and leukemia. Although it affects the brain, people with AT usually have normal or above normal intelligence.
AT has no cure. Treatments might improve some symptoms. They include injections to strengthen the immune system, physical and speech therapy, and high-dose vitamin therapy.
NIH: National Institute of Neurological Disorders and Stroke
References and abstracts from MEDLINE/PubMed (National Library of Medicine)